Tamoxifen aziridines: Effective inactivators of the estrogen receptor

David W. Robertson, Lisa L. Wei, James R. Hayes, Kathryn E. Carlson, John A. Katzenellenbogen, Benita S Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

Two analogs of the antiestrogen tamoxifen, which bear a chemically reactive aziridine function in place of the dimethylamino group, bind to the estrogen receptor from rat uterus and from MCF-7 human breast cancer cells and appear to react irreversibly with the receptor at the estrogen binding site, in a time-and concentration-dependent fashion. Because these compounds are effective receptor inactivators in uterus and breast cancer cells, they should prove to be useful probes for investigating the role of receptor in regulating cellular responses to estrogen and in studying the dynamics of estrogen receptor synthesis and turnover.

Original languageEnglish (US)
Pages (from-to)1298-1300
Number of pages3
JournalEndocrinology
Volume109
Issue number4
DOIs
StatePublished - Oct 1981

Fingerprint

Estrogen Receptors
Breast Neoplasms
Uterine Neoplasms
Estrogen Receptor Modulators
Tamoxifen
Uterus
Estrogens
Binding Sites
tamoxifen aziridine
aziridine

ASJC Scopus subject areas

  • Endocrinology

Cite this

Robertson, D. W., Wei, L. L., Hayes, J. R., Carlson, K. E., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1981). Tamoxifen aziridines: Effective inactivators of the estrogen receptor. Endocrinology, 109(4), 1298-1300. https://doi.org/10.1210/endo-109-4-1298

Tamoxifen aziridines : Effective inactivators of the estrogen receptor. / Robertson, David W.; Wei, Lisa L.; Hayes, James R.; Carlson, Kathryn E.; Katzenellenbogen, John A.; Katzenellenbogen, Benita S.

In: Endocrinology, Vol. 109, No. 4, 10.1981, p. 1298-1300.

Research output: Contribution to journalArticle

Robertson, DW, Wei, LL, Hayes, JR, Carlson, KE, Katzenellenbogen, JA & Katzenellenbogen, BS 1981, 'Tamoxifen aziridines: Effective inactivators of the estrogen receptor', Endocrinology, vol. 109, no. 4, pp. 1298-1300. https://doi.org/10.1210/endo-109-4-1298
Robertson DW, Wei LL, Hayes JR, Carlson KE, Katzenellenbogen JA, Katzenellenbogen BS. Tamoxifen aziridines: Effective inactivators of the estrogen receptor. Endocrinology. 1981 Oct;109(4):1298-1300. https://doi.org/10.1210/endo-109-4-1298
Robertson, David W. ; Wei, Lisa L. ; Hayes, James R. ; Carlson, Kathryn E. ; Katzenellenbogen, John A. ; Katzenellenbogen, Benita S. / Tamoxifen aziridines : Effective inactivators of the estrogen receptor. In: Endocrinology. 1981 ; Vol. 109, No. 4. pp. 1298-1300.
@article{fabdd771e00d49feb071351b9b44b062,
title = "Tamoxifen aziridines: Effective inactivators of the estrogen receptor",
abstract = "Two analogs of the antiestrogen tamoxifen, which bear a chemically reactive aziridine function in place of the dimethylamino group, bind to the estrogen receptor from rat uterus and from MCF-7 human breast cancer cells and appear to react irreversibly with the receptor at the estrogen binding site, in a time-and concentration-dependent fashion. Because these compounds are effective receptor inactivators in uterus and breast cancer cells, they should prove to be useful probes for investigating the role of receptor in regulating cellular responses to estrogen and in studying the dynamics of estrogen receptor synthesis and turnover.",
author = "Robertson, {David W.} and Wei, {Lisa L.} and Hayes, {James R.} and Carlson, {Kathryn E.} and Katzenellenbogen, {John A.} and Katzenellenbogen, {Benita S}",
year = "1981",
month = "10",
doi = "10.1210/endo-109-4-1298",
language = "English (US)",
volume = "109",
pages = "1298--1300",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Tamoxifen aziridines

T2 - Effective inactivators of the estrogen receptor

AU - Robertson, David W.

AU - Wei, Lisa L.

AU - Hayes, James R.

AU - Carlson, Kathryn E.

AU - Katzenellenbogen, John A.

AU - Katzenellenbogen, Benita S

PY - 1981/10

Y1 - 1981/10

N2 - Two analogs of the antiestrogen tamoxifen, which bear a chemically reactive aziridine function in place of the dimethylamino group, bind to the estrogen receptor from rat uterus and from MCF-7 human breast cancer cells and appear to react irreversibly with the receptor at the estrogen binding site, in a time-and concentration-dependent fashion. Because these compounds are effective receptor inactivators in uterus and breast cancer cells, they should prove to be useful probes for investigating the role of receptor in regulating cellular responses to estrogen and in studying the dynamics of estrogen receptor synthesis and turnover.

AB - Two analogs of the antiestrogen tamoxifen, which bear a chemically reactive aziridine function in place of the dimethylamino group, bind to the estrogen receptor from rat uterus and from MCF-7 human breast cancer cells and appear to react irreversibly with the receptor at the estrogen binding site, in a time-and concentration-dependent fashion. Because these compounds are effective receptor inactivators in uterus and breast cancer cells, they should prove to be useful probes for investigating the role of receptor in regulating cellular responses to estrogen and in studying the dynamics of estrogen receptor synthesis and turnover.

UR - http://www.scopus.com/inward/record.url?scp=0019499401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019499401&partnerID=8YFLogxK

U2 - 10.1210/endo-109-4-1298

DO - 10.1210/endo-109-4-1298

M3 - Article

C2 - 7285873

AN - SCOPUS:0019499401

VL - 109

SP - 1298

EP - 1300

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 4

ER -